That's starting to wander into dry-aged beef ribeye territory at a higher-end version of common grocery chains, and sale pricing numbers at Whole Foods Market. It predictably starts out as a luxury good, but as others have noted, cell culture-based processes have historically scaled pretty effectively. So probably 2-3 more decades after that with continuous refinements will bring it down to a price point that even the middle class will look at, so that's pretty exciting it is getting so close.
What is the regulatory outlook for these products? Will they be regulated as pharmaceutical (due to the bioreactor origin) or food, or is this an issue currently being negotiated and discussed with government? I imagine investors would strongly prefer a food regulatory treatment.